BACKGROUND: Recent studies have shown that indigenous hepatitis E virus (HEV) strains cause hepatitis E in industrialized countries. We aimed to clarify the characteristics of HEV infection in sporadic hepatitis patients during the last decade in Miyagi, northeast Japan. METHODS: We analyzed 94 serum samples obtained from acute or fulminant hepatitis patients of non-A, non-B, and non-C etiology between 1999 and 2008. Antibody to HEV (anti-HEV) was assayed, and patients who were positive for IgM- and/or IgA-class anti-HEV were diagnosed with hepatitis E. HEV RNA was tested in these patients, and phylogenetic analysis was performed. The occurrence of hepatitis E was compared with that of hepatitis A. RESULTS: Eight acute hepatitis patients (8.5%) were diagnosed with hepatitis E, and HEV RNA was detectable in seven patients. Five isolates of HEV were segregated into genotype 3 and the remaining two isolates into genotype 4. The year of the occurrence of hepatitis E was distributed almost equally from 1999 to 2008, whereas the cases of acute hepatitis A (n = 16) have decreased markedly in the last several years. In 2004-2008, the occurrence of hepatitis E was greater than that of hepatitis A (five cases vs. one case). As for seasonality, hepatitis E occurred more frequently from September to December than hepatitis A (five cases vs. four cases), although less frequently from January to April (one case vs. seven cases). CONCLUSION: The occurrence of hepatitis E has not decreased during the last decade in northeast Japan, in contrast to hepatitis A.
BACKGROUND: Recent studies have shown that indigenous hepatitis E virus (HEV) strains cause hepatitis E in industrialized countries. We aimed to clarify the characteristics of HEV infection in sporadic hepatitispatients during the last decade in Miyagi, northeast Japan. METHODS: We analyzed 94 serum samples obtained from acute or fulminant hepatitispatients of non-A, non-B, and non-C etiology between 1999 and 2008. Antibody to HEV (anti-HEV) was assayed, and patients who were positive for IgM- and/or IgA-class anti-HEV were diagnosed with hepatitis E. HEV RNA was tested in these patients, and phylogenetic analysis was performed. The occurrence of hepatitis E was compared with that of hepatitis A. RESULTS: Eight acute hepatitispatients (8.5%) were diagnosed with hepatitis E, and HEV RNA was detectable in seven patients. Five isolates of HEV were segregated into genotype 3 and the remaining two isolates into genotype 4. The year of the occurrence of hepatitis E was distributed almost equally from 1999 to 2008, whereas the cases of acute hepatitis A (n = 16) have decreased markedly in the last several years. In 2004-2008, the occurrence of hepatitis E was greater than that of hepatitis A (five cases vs. one case). As for seasonality, hepatitis E occurred more frequently from September to December than hepatitis A (five cases vs. four cases), although less frequently from January to April (one case vs. seven cases). CONCLUSION: The occurrence of hepatitis E has not decreased during the last decade in northeast Japan, in contrast to hepatitis A.
Authors: P Y Kwo; G G Schlauder; H A Carpenter; P J Murphy; J E Rosenblatt; G J Dawson; E E Mast; K Krawczynski; V Balan Journal: Mayo Clin Proc Date: 1997-12 Impact factor: 7.616
Authors: S Fukuda; M Ishikawa; N Ochiai; Y Suzuki; J Sunaga; N Shinohara; K Nozawa; F Tsuda; M Takahashi; H Okamoto Journal: Arch Virol Date: 2007-05-29 Impact factor: 2.574
Authors: Julio Rendon; Maria Cristina Hoyos; Diana di Filippo; Fabian Cortes-Mancera; Carolina Mantilla; Maria Mercedes Velasquez; Maria Elsy Sepulveda; Juan Carlos Restrepo; Sergio Jaramillo; Maria Patricia Arbelaez; Gonzalo Correa; Maria-Cristina Navas Journal: PLoS One Date: 2016-02-17 Impact factor: 3.240
Authors: Nara Rubia de Freitas; Edna Braz Rocha de Santana; Ágabo Macedo da Costa E Silva; Sueli Meira da Silva; Sheila Araújo Teles; Noemi Rovaris Gardinali; Marcelo Alves Pinto; Regina Maria Bringel Martins Journal: Mem Inst Oswaldo Cruz Date: 2016-10-13 Impact factor: 2.743